Furthermore, tanshinone IIA (1) ameliorated DSS-induced inflammatory bowel disease (IBD) through the pregnenolone X receptor (PXR)-mediated upregulation of exogenous metabolism and the downregulation of NF-κB signaling [100]. This evidence concerns the gene NFKB1 and inflammatory bowel disease.